Table 2. Part 2.

Characteristics of surviving and deceased patients with enterococcal or nonenterococcal bacteremia

	Enterococcal bacteremia					Nonenterococcal bacteremia
	Survived		Deceased		Incomplete data sets	Survived		Deceased		Incomplete data sets
	(n)	(%)	(n)	(%)	(n)	(n)	(%)	(n)	(%)	(n)
Procalcitonin
≥0.5 × 10–5g/1	26	90	18	95	219	70	89	33	97	548
<0.5 × 10–5 g/1	3	10	1	5		9	11	1	3
Presence of urinary catheters
Yes	152	98	48	98	63	359	85	96	97	142
No	3	2	1	2		61	15	3	3
Detection of leukocytes in urine
Yes	45	48	6	29	152	172	58	25	53	315
No	49	52	15	71		127	42	22	47
Detection of bacteria in urine samples
Yes	33	42	7	30	165	146	57	30	64	357
No	46	58	16	70		111	43	17	36
Treatment on intensive care unit required
Yes	103	66	36	77	63	125	30	64	63	148
No	54	34	11	23		287	70	37	37
Need for catecholamines
Yes	65	42	31	66	64	67	16	52	51	147
No	91	58	16	34		346	84	49	49
Need for invasive ventilation
Yes	60	38	30	64	63	46	11	36	36	145
No	97	62	17	36		369	89	65	64
Antibiotic therapy at time point of sample acquisition
Yes	100	65	41	85	64	173	42	71	71	146
No	55	35	7	5		242	58	29	29
Main diagnosis sepsis
Yes	18	11	10	20	61	159	38	30	30	141
No	139	89	39	80		260	62	71	70
Isolates from bronchoalveolar lavage
Yes	1	3	2	25	229	3	12	3	27	624
No	29	97	6	75		23	88	8	73